Back to Search
Start Over
Clusters of comorbidities in idiopathic pulmonary fibrosis.
- Source :
-
Respiratory medicine [Respir Med] 2021 Aug-Sep; Vol. 185, pp. 106490. Date of Electronic Publication: 2021 Jun 01. - Publication Year :
- 2021
-
Abstract
- Introduction: Comorbidities are common in patients with idiopathic pulmonary fibrosis (IPF) and negatively impact health-related quality of life, health-care costs and mortality. Retrospective studies have focused on individual comorbidities, but clusters of multiple comorbidities have rarely been analysed. This study aimed to comprehensively and prospectively assess comorbidities in a multicentre, real-world cohort of patients with IPF, including prespecified conditions of special interest and to analyse clusters of comorbidities and examine characteristics, disease course and mortality of the clusters.<br />Methods: Several measurements, questionnaires, medications and medical history were combined to assess comorbidities. Using self-organizing maps, clusters of comorbidities were identified and phenotypes characterized. Disease course was assessed using mixed effects models and mortality using Cox regression.<br />Results: One-hundred and fifty IPF patients were included prospectively. All except one patient suffered from at least one comorbidity and multimorbidity was common. Arterial hypertension, gastro-oesophageal reflux disease, hypercholesterolemia, emphysema and obstructive sleep apnea were most prevalent. Four comorbidity clusters were identified. Each cluster had distinct comorbidity profiles, patient characteristics, symptom burden and disease severity. Patients with fewer comorbidities had better exercise capacity and less dyspnea at baseline, but a trend towards faster deterioration was observed. Mortality analyses showed no significant differences between clusters.<br />Conclusions: Multimorbidity is prevalent in patients with IPF. Four specific clusters of comorbidities may represent phenotypes in IPF. A trend towards faster decline in exercise capacity and dyspnea was observed in patients with fewer comorbidities. Increased knowledge of comorbidities facilitates prevention and treatment of comorbidities in patients with IPF.<br /> (Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Subjects :
- Aged
Cluster Analysis
Comorbidity
Dyspnea epidemiology
Dyspnea etiology
Dyspnea prevention & control
Emphysema epidemiology
Emphysema prevention & control
Exercise Tolerance
Female
Gastroesophageal Reflux epidemiology
Gastroesophageal Reflux prevention & control
Health Care Costs
Humans
Hypercholesterolemia epidemiology
Hypercholesterolemia prevention & control
Hypertension epidemiology
Hypertension prevention & control
Idiopathic Pulmonary Fibrosis economics
Idiopathic Pulmonary Fibrosis mortality
Idiopathic Pulmonary Fibrosis physiopathology
Male
Phenotype
Prevalence
Prospective Studies
Quality of Life
Sleep Apnea, Obstructive epidemiology
Sleep Apnea, Obstructive prevention & control
Surveys and Questionnaires
Idiopathic Pulmonary Fibrosis epidemiology
Subjects
Details
- Language :
- English
- ISSN :
- 1532-3064
- Volume :
- 185
- Database :
- MEDLINE
- Journal :
- Respiratory medicine
- Publication Type :
- Academic Journal
- Accession number :
- 34130097
- Full Text :
- https://doi.org/10.1016/j.rmed.2021.106490